Background Although COVID-19 vaccination decreases the risk of severe illness, it is
unclear whether vaccine administration may impact the prevalence of long-COVID. The aim …

A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …

Despite notable scientific and medical advances, broader political, socioeconomic and
behavioural factors continue to undercut the response to the COVID-19 pandemic 1, 2. Here …

To combat future severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
and spillovers of SARS-like betacoronaviruses (sarbecoviruses) threatening global health …

IJERPH | Free Full-Text | Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in
the Real World: A Systematic Review and Meta-Analysis Next Article in Journal Cost and …

The coronavirus infectious disease (COVID-19) shows a remarkable symptomatic
heterogeneity. Several risk factors including advanced age, previous illnesses, and a …

Coronavirus disease 2019 (COVID‐19) is a continued leading cause of hospitalization and
death. Safe, efficacious COVID‐19 antivirals are needed urgently. Nirmatrelvir (PF …

To date, around 60% of the world population has been protected by vaccines against SARS-
CoV-2, significantly reducing the devastating effect of the pandemic and restoring social …

Knowing vaccine effectiveness (VE) against variants of concern (VOCs) in the real-world
setting is essential for public health decision-making. A systematic landscape of the VE …

This cross-sectional study, conducted in Naples (Italy) between 16 November and 6
December 2021, explored the willingness to receive the booster dose of the COVID-19 …